Record Display for the EPA National Library Catalog

RECORD NUMBER: 218 OF 1241

OLS Field Name OLS Field Data
Main Title Cell Engineering Apoptosis / [electronic resource] :
Type EBOOK
Author Al-Rubeai, Mohamed.
Other Authors
Author Title of a Work
Fussenegger, Martin.
Publisher Springer Netherlands,
Year Published 2005
Call Number QL801-950.9
ISBN 9781402022173
Subjects Life sciences. ; Biochemical engineering. ; Biochemistry. ; Morphology (Animals).
Internet Access
Description Access URL
http://dx.doi.org/10.1007/1-4020-2217-4
Collation X, 334 p. online resource.
Notes
Due to license restrictions, this resource is available to EPA employees and authorized contractors only
Contents Notes
Caspase Regulation at the Molecular Level -- The Bcl-2 Family -- The IGF-1 Receptor in Cell Survival: Signalling and Regulation -- Apoptosis in Hepatocytes -- Programmed Cell Death in Plants During Development and Stress Responses -- A Systems View of Cell Death -- The Role of Caspases in Apoptosis and Their Inhibition in Mammalian Cell Culture -- Improvement of Industrial Cell Culture Processes by Caspase-9 Dominant Negative and Other Apoptotic Inhibitors -- Therapeutic Small Molecule Inhibitors of Bcl-2 -- Apoptosis Control Based on Down-Regulating the Inhibitor-of-Apoptosis (IAP) Proteins: Xiap Antisense and Other Approaches -- Monitoring of Apoptosis -- Molecular Imaging of Programmed Cell Death; from Basic Mechanisms to Clinical Applications. The suppression of apoptosis by the IGF system is critical for normal cell development, proliferation, differentiation and motility. Aberrations in IGF signalling mechanisms contribute to cell transformation, tumour progression and metastasis. Many questions remain to be answered as to how exactly the IGF system mediates its effects both in normal and tumour cells and how the IGF-1R interacting proteins and downstream signalling cascades are regulated. The importance of the IGF system is underscored by the significant interest in the development of anti-IGF therapies for IGF sensitive cancers. Future developments in cancer therapy are likely to focus on methods to target these therapies to diseased but not normal cells. 14. Acknowledgements We would like to thank Kurt Tidmore for preparing the illustrations. The Health Research Board of Ireland and Science Foundation Ireland are grateful acknowledged for funding. 15. References Adamo M., Roberts C. T., Jr. and LeRoith D. (1992) How distinct are the insulin and insul- like growth factor I signalling systems? Biofactors 3, 151-7. Adams T. E., Epa V. C., Garrett T. P. and Ward C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57, 1050-93. Adler V., Polotskaya A., Wagner F. and Kraft A. S. (1992) Affinity-purified c-Jun ami- terminal protein kinase requires serine/threonine phosphorylation for activity. J Biol Chem 267, 17001-5.